Singular and combined effects of nebivolol and lifestyle modification on large artery stiffness in hypertensive adults

Therapeutic Advances in Cardiovascular Disease

Volumn 7, Issue 6, 2013, Pages 285-292

  Werner, Timothy J ^a   Boutagy, Nabil E ^a   Osterberg, Kristin L ^a   Rivero, Jose M ^a   Davy, Kevin P ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

antihypertensive; arterial distensibility; beta blocker

Indexed keywords

C REACTIVE PROTEIN; CARBOHYDRATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; MONOUNSATURATED FATTY ACID; NEBIVOLOL; ORAL CONTRACEPTIVE AGENT; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYUNSATURATED FATTY ACID; POTASSIUM; SATURATED FATTY ACID; SODIUM; TRACE ELEMENT; TRANS FATTY ACID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTERIAL PRESSURE; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BETA STIFFNESS INDEX; BLOOD VESSEL PARAMETERS; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; BRACHIAL ARTERY; CALORIC INTAKE; CALORIC RESTRICTION; CARBOHYDRATE INTAKE; CARDIOMETABOLIC RISK; CAROTID ARTERY; CENTRIFUGAL ANALYZER; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DETERIORATION; DIASTOLIC BLOOD PRESSURE; DIETARY FIBER; DIETARY INTAKE; DRUG DOSE TITRATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; ELISA KIT; FAT FREE MASS; FAT INTAKE; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOTHESIS; IMAGING SOFTWARE; INSULIN BLOOD LEVEL; LIFESTYLE MODIFICATION; LIPOPROTEIN BLOOD LEVEL; MACRONUTRIENT; MALE; MIDDLE AGED; MONOTHERAPY; PEDOMETER; PHYSICAL ACTIVITY; POSTMENOPAUSE; POTASSIUM INTAKE; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTING HEART RATE; SODIUM INTAKE; SPHYGMOMANOMETER; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE; TONOMETRY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ANTIHYPERTENSIVE; ARTERIAL DISTENSIBILITY; BETA-BLOCKER;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ARTERIAL PRESSURE; BENZOPYRANS; CALORIC RESTRICTION; COMBINED MODALITY THERAPY; ETHANOLAMINES; EXERCISE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK REDUCTION BEHAVIOR; TIME FACTORS; TREATMENT OUTCOME; VASCULAR STIFFNESS; VASODILATOR AGENTS; VIRGINIA; WEIGHT LOSS;

EID: 84890465537     PISSN: 17539447     EISSN: 17539455     Source Type: Journal    
DOI: 10.1177/1753944713513062     Document Type: Article

References (30)

1. Agabiti-Rosei E. Porteri E. Rizzoni D. (2009) Arterial stiffness, hypertension, and rational use of nebivolol. Vasc Health Risk Manag 5: 353–360.
2. Avolio A. Chen S. Wang R. Zhang C. Li M. O'Rourke M. (1983) Effects of aging on change arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 68: 50–58.
3. Ayers K. Byrne L. de Matteo A. Brown N. (2012) Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome. Hypertension 59: 893–898.
4. Bell D. Bakris G. McGill J. (2009) Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients. Diabetes Obes Metab 11: 234–238.
5. Boutouyrie P. Tropeano A. Asmar R. Gautier I. Benetos A. Lacolley P. et al. (2002) Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 39: 10–15.
6. Chobanian A. Bakris G. Black H. Cushman W. Green L. Izzo J. Jr et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560–2572.
7. Cooper J. Buchanich J. Youk A. Brooks M. Barinas-Mitchell E. Conroy M. et al. (2012) Reductions in arterial stiffness with weight loss in overweight and obese young adults: potential mechanisms. Atherosclerosis 223: 485–490.
8. Dengo A. Dennis E. Orr J. Marinik E. Ehrlich E. Davy B. et al. (2010) Arterial destiffening with weight loss in overweight and obese middle-aged and older adults. Hypertension 55: 855–861.
9. Dhakam Z. McEniery C. Burton T. Brown M. Wilkinson I. (2008) A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens 26: 351–356.
10. Gates P. Tanaka H. Hiatt W. Seals D. (2004) Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension. Hypertension 44: 35–41.
11. Hughes T. Althouse A. Niemczyk N. Hawkins M. Kuipers A. Sutton-Tyrrell K. (2012) Effects of weight loss and insulin reduction on arterial stiffness in the SAVE trial. Cardiovasc Diabetol 11: 114.
12. Jacob S. Rett K. Wicklmayr M. Agrawal B. Augustin H. Dietze G. (1996) Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study. J Hypertens 14: 489–494.
13. Laurent S. Boutouyrie P. Asmar R. Gautier I. Laloux B. Guize L. et al. (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37: 1236–1241.
14. Laurent S. Katsahian S. Fassot C. Tropeano A. Gautier I. Laloux B. et al. (2003) Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 34: 1203–1206.
15. Liao D. Arnett D.K. Tyroler H.A. Riley W.A. Chambless L.E. Szklo M. et al. (1999) Arterial stiffness and the development of hypertension. The ARIC study. Hypertension 34 (2): 201–206.
16. Mackenzie I. McEniery C. Dhakam Z. Brown M. Cockcroft J. Wilkinson I. (2009) Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension 54: 409–413.
17. Maffei A. Lembo G. (2009) Nitric oxide mechanisms of nebivolol. Ther Adv Cardiovasc Dis 3: 317–327.
18. Orr J.S. Dengo A.L. Rivero J.M. Davy K.P. (2009). Arterial destiffening with atorvastatin in overweight and obese middle-aged and older adults. Hypertension 54 (4): 763–768.
19. Pickering T. Hall J. Appel L. Falkner B. Graves J. Hill M. et al. (2005) Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 45: 142–161.
20. Seals D. Tanaka H. Clevenger C. Monahan K. Reiling M. Hiatt W. et al. (2001) Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness. J Am Coll Cardiol 38: 506–513.
21. Serg M. Kampus P. Kals J. Zagura M. Zilmer M. Zilmer K. et al. (2012) Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension. Scand J Clin Lab Invest 72: 427–432.
22. Simova I. Todorova-Konstantinova R. Denchev S. (2009) Effects of nebivolol versus bisoprolol on endothelial function in hypertensive patients. Exp Clin Cardiol 14 (4): 45–49.
23. Soanker R. Naidu M. Raju S. Prasad A. Rao T. (2012) Effect of beta-1-blocker, nebivolol, on central aortic pressure and arterial stiffness in patients with essential hypertension. Indian J Pharmacol 44: 407–411.
24. Sutton-Tyrrell K. Newman A. Simonsick E. Havlik R. Pahor M. Lakatta E. et al. (2001) Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension 38: 429–433.
25. Tanaka H. Dinenno F. Monahan K. Clevenger C. de Souza C. Seals D. (2000) Aging, habitual exercise, and dynamic arterial compliance. Circulation 102: 1270–1275.
26. Vaitkevicius P. Fleg J. Engel J. O'Connor F. Wright J. Lakatta L. et al. (1993) Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 88: 1456–1462.
27. Vanhoutte P. Gao Y. (2013) Beta blockers, nitric oxide, and cardiovascular disease. Curr Opin Pharmacol 13: 265–273.
28. Wildman R. Mackey R. Bostom A. Thompson T. Sutton-Tyrrell K. (2003) Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension 42: 468–473.
29. Williams B. Lacy P. Thom S. Cruickshank K. Stanton A. Collier D. et al. (2006) Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113: 1213–1225.
30. Wojciechowski D. Papademetriou V. (2008) Beta-blockers in the management of hypertension: focus on nebivolol. Expert Rev Cardiovasc Ther 6: 471–479.